Total joint replacement: A consideration for antimicrobial prophylaxis

Oral Surgery, Oral Medicine, Oral Pathology

Volumn 66, Issue 1, 1988, Pages 124-129

  Cioffi, G A ^a   Terezhalmy, G T ^b   Taybos, G M ^c  

^a Naval Dental Clinic   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE;

DENTAL CARE; HUMAN; JOINT PROSTHESIS; REVIEW; SEPTICEMIA; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

ANTIBIOTICS; CEPHALOSPORINS; DENTAL CARE FOR DISABLED; HUMAN; JOINT PROSTHESIS; SEPTICEMIA; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 0024042428     PISSN: 00304220     EISSN: None     Source Type: Journal    
DOI: 10.1016/0030-4220(88)90079-5     Document Type: Article

References (38)

1. Late infections in patients with prostheses for total replacement of joints: implications for the dental practitioner
2. The problem of infection in total prosthetic arthroplasty of the hip
3. The number of joint replacements in the United States
4. Infected total hip replacement after dental procedures
5. Factors influencing the incidence and outcome of infection following total joint arthroplasty
6. Prosthetic joint infection and dental procedures
7. The natural history of the patient with an infected total hip replacement
8. Postoperative infection after total hip replacement with special reference to air contamination in the operating room
9. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty
10. Prophylactic coverage of dental patients with artificial joints a retrospective analysis of thirty-three infections in hip prostheses
11. Antibiotic prophylaxis in total hip replacement
12. Deep wound sepsis following total hip arthroplasty
13. Hematogenous infection in total joint replacement
14. Hematogenous infection of total joint replacement an experimental study in the rabbit
15. Infection in rheumatoid arthritis
16. Prophylactic antibiotics against early and late deep infections after total hip replacements
17. Death rate and causes of death in rheumatoid arthritis patients during a period of 5 years
18. The need for antibiotic coverage for dental treatment of patients with joint replacements
19. Prophylactic use of antimicrobial agents
20. Contamination of the operative wound
21. Infection after total joint arthroplasty from distal extremity sepsis
22. Deep infection following total hip arthroplasty
23. Late hematogenous infection of total joint replacement
24. Prophylactic antibiotics in hip fractures
25. Bone and serum concentrations of five cephalosporin drugs
26. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement
27. Transient bacteremia and endocarditis prophylaxis
28. Penicillin prophylaxis of experimental staphylococcal wound infections
29. Dental treatment and late prosthetic joint infections
30. Experimental endocarditis: Staphylococcal endocarditis in rabbits resulting from placement of polyethylene catheter in the right side of the heart
31. Chemotherapy of experimental streptococcal endocarditis: comparison of commonly recommended prophylactic regimens
32. Chemotherapy of experimental streptococcal endocarditis: further observations on prophylaxis
33. Protective effect of prophylactic penicillin on splenectomized mice exposed to an aerosolized suspension of Type III Streptococcus pneumoniae
34. Infections in total hips secondary to a primary source elsewhere
35. The effective period of preventive antibiotic action in experimental incisions and dermal lesions
36. Antibiotic prophylaxis in experimental bone infections
37. Secondarily infected total joint replacements by hematogenous spread